Bromocriptine approved as the first medication to target dopamine activity to improve glycemic control in patients with type 2 diabetes.
about
Management of hyperglycemia in geriatric patients with diabetes mellitus: South Asian consensus guidelines.Bromocriptine in type 2 diabetes mellitusRandomized pilot study of cabergoline, a dopamine receptor agonist: effects on body weight and glucose tolerance in obese adultsManagement of type-2 diabetes mellitus in adults: focus on individualizing non-insulin therapies.Efficacy of bromocriptine on glycemic and metabolic control of prediabetic patients.Functional analysis of the gene controlling hydroxylation of festuclavine in the ergot alkaloid pathway of Neosartorya fumigataEfficacy and safety of add on therapy of bromocriptine with metformin in Indian patients with type 2 diabetes mellitus: a randomized open labeled phase IV clinical trial.Obesity in bipolar disorder: an overview.The importance of synthetic drugs for type 2 diabetes drug discovery.Repositioning of bromocriptine for treatment of acute myeloid leukemia.Bromocriptine inhibits adipogenesis and lipogenesis by agonistic action on α2-adrenergic receptor in 3T3-L1 adipocyte cells.The effect of the ANKK1/DRD2 Taq1A polymorphism on weight changes of dopaminergic treatment in prolactinomas.
P2860
Q35073384-D398A37A-566C-47B0-8956-933E5D370519Q35153082-6F4903D3-D036-4112-A7C8-EC09B358B528Q35791125-FAAFA9C5-72FA-4190-AE3B-9CF7CD70588DQ36523427-0ACD48DD-5A16-4ADD-8F3C-E8DB26CDE387Q36560960-0EA7C802-E04F-48DC-8981-728D71DDEE1DQ37256278-A840D9AF-A2A7-4F9E-8703-A588C4CB43ABQ37551483-0F03A55F-71A3-4DB0-9B11-EFE8346342E8Q38035727-1E6621CC-57BD-4443-90BA-3241FCEC074CQ38139508-17270C47-E53F-4E97-9FF3-F1E4250645CEQ41040260-997CAA13-F2F5-4AA5-9BD0-DF7B4A467029Q42827441-724533EC-1DF6-4112-83B1-640AB6B488BFQ47230953-F92A0448-1A77-4BD2-AF13-D9BC345AE8AB
P2860
Bromocriptine approved as the first medication to target dopamine activity to improve glycemic control in patients with type 2 diabetes.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Bromocriptine approved as the ...... patients with type 2 diabetes.
@ast
Bromocriptine approved as the ...... patients with type 2 diabetes.
@en
Bromocriptine approved as the ...... patients with type 2 diabetes.
@nl
type
label
Bromocriptine approved as the ...... patients with type 2 diabetes.
@ast
Bromocriptine approved as the ...... patients with type 2 diabetes.
@en
Bromocriptine approved as the ...... patients with type 2 diabetes.
@nl
prefLabel
Bromocriptine approved as the ...... patients with type 2 diabetes.
@ast
Bromocriptine approved as the ...... patients with type 2 diabetes.
@en
Bromocriptine approved as the ...... patients with type 2 diabetes.
@nl
P2093
P2860
P356
P1476
Bromocriptine approved as the ...... patients with type 2 diabetes.
@en
P2093
Himani Chandra
Maria Skamagas
Matthew V Potenza
Michael A Via
Takako Araki
P2860
P356
10.2147/DMSOTT.S9575
P577
2010-03-26T00:00:00Z